156 related articles for article (PubMed ID: 15105810)
1. Immunohistochemical detection of BCL-3 in lymphoid neoplasms: a survey of 353 cases.
Canoz O; Rassidakis GZ; Admirand JH; Medeiros LJ
Mod Pathol; 2004 Aug; 17(8):911-7. PubMed ID: 15105810
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma.
Admirand JH; Rassidakis GZ; Abruzzo LV; Valbuena JR; Jones D; Medeiros LJ
Mod Pathol; 2004 Aug; 17(8):954-61. PubMed ID: 15133473
[TBL] [Abstract][Full Text] [Related]
3. Clusterin expression in malignant lymphomas: a survey of 266 cases.
Saffer H; Wahed A; Rassidakis GZ; Medeiros LJ
Mod Pathol; 2002 Nov; 15(11):1221-6. PubMed ID: 12429802
[TBL] [Abstract][Full Text] [Related]
4. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas.
Dogan A; Bagdi E; Munson P; Isaacson PG
Am J Surg Pathol; 2000 Jun; 24(6):846-52. PubMed ID: 10843287
[TBL] [Abstract][Full Text] [Related]
5. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
Nguyen PL; Harris NL; Ritz J; Robertson MJ
Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of WT1 gene product in non-Hodgkin lymphomas.
Drakos E; Rassidakis GZ; Tsioli P; Lai R; Jones D; Medeiros LJ
Appl Immunohistochem Mol Morphol; 2005 Jun; 13(2):132-7. PubMed ID: 15894924
[TBL] [Abstract][Full Text] [Related]
7. Regulation of TCL1 expression in B- and T-cell lymphomas and reactive lymphoid tissues.
Narducci MG; Pescarmona E; Lazzeri C; Signoretti S; Lavinia AM; Remotti D; Scala E; Baroni CD; Stoppacciaro A; Croce CM; Russo G
Cancer Res; 2000 Apr; 60(8):2095-100. PubMed ID: 10786666
[TBL] [Abstract][Full Text] [Related]
8. [Abnormal expression of bcl-10 protein in extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue lymphoma type].
Li BZ; Zhou XY; Ye HT; Yang WT; Fan YZ; Lu HF; Shi DR
Zhonghua Bing Li Xue Za Zhi; 2007 Dec; 36(12):819-24. PubMed ID: 18346354
[TBL] [Abstract][Full Text] [Related]
9. New developments in non-Hodgkin lymphoid malignancies.
Ganapathi KA; Brown LE; Prakash S; Bhargava P
Pathology; 2021 Apr; 53(3):349-366. PubMed ID: 33685720
[TBL] [Abstract][Full Text] [Related]
10. Class III beta-tubulin shows unique expression patterns in a variety of neoplastic and non-neoplastic lymphoproliferative disorders.
Yoon SO; Kim WY; Go H; Paik JH; Kim JE; Kim YA; Huh JR; Jeon YK; Kim CW
Am J Surg Pathol; 2010 May; 34(5):645-55. PubMed ID: 20220512
[TBL] [Abstract][Full Text] [Related]
11. Bcl-2 oncoprotein is widespread in lymphoid tissue and lymphomas but its differential expression in benign versus malignant follicles and monocytoid B-cell proliferations is of diagnostic value.
Wang T; Lasota J; Hanau CA; Miettinen M
APMIS; 1995 Sep; 103(9):655-62. PubMed ID: 7488387
[TBL] [Abstract][Full Text] [Related]
12. Bcl-6 protein expression by follicle center lymphomas. A marker for differentiating follicle center lymphomas from other low-grade lymphoproliferative disorders.
Raible MD; Hsi ED; Alkan S
Am J Clin Pathol; 1999 Jul; 112(1):101-7. PubMed ID: 10396291
[TBL] [Abstract][Full Text] [Related]
13. Expression of heat-shock protein-90 in non-Hodgkin's lymphomas.
Valbuena JR; Rassidakis GZ; Lin P; Atwell C; Georgakis GV; Younes A; Jones D; Medeiros LJ
Mod Pathol; 2005 Oct; 18(10):1343-9. PubMed ID: 16056252
[TBL] [Abstract][Full Text] [Related]
14. Expression of bcl-2 oncogene product in primary non-Hodgkin's malignant lymphoma of the oral cavity.
Takahashi H; Kawazoe K; Fujita S; Okabe H; Hideshima K; Tsuda N; Tezuka F
Pathol Res Pract; 1996 Jan; 192(1):44-53. PubMed ID: 8685041
[TBL] [Abstract][Full Text] [Related]
15. Distribution and ZAP-70 expression of WHO lymphoma categories in Shanxi, China: a review of 447 cases using a tissue microarray technique.
Wang J; Young L; Win W; Taylor CR
Appl Immunohistochem Mol Morphol; 2005 Dec; 13(4):323-32. PubMed ID: 16280661
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry.
Zukerberg LR; Yang WI; Arnold A; Harris NL
Am J Clin Pathol; 1995 Jun; 103(6):756-60. PubMed ID: 7540362
[TBL] [Abstract][Full Text] [Related]
17. Detection of the apoptosis-suppressing oncoprotein bcl-2 in salivary gland lymphoma.
Takahashi H; Fujita S; Shibata Y; Okabe H; Hideshima K; Tsuda N
Pathol Res Pract; 1998; 194(3):163-70. PubMed ID: 9587934
[TBL] [Abstract][Full Text] [Related]
18. The World Health Organization classification of malignant lymphoma: incidence and clinical prognosis in HTLV-1-endemic area of Fukuoka.
Ohshima K; Suzumiya J; Kikuchi M
Pathol Int; 2002 Jan; 52(1):1-12. PubMed ID: 11940200
[TBL] [Abstract][Full Text] [Related]
19. Ovarian non-Hodgkin's lymphoma: a clinicopathologic study of eight primary cases.
Vang R; Medeiros LJ; Warnke RA; Higgins JP; Deavers MT
Mod Pathol; 2001 Nov; 14(11):1093-9. PubMed ID: 11706069
[TBL] [Abstract][Full Text] [Related]
20. Immunolocalization of the Bcl-2 protein within hematopoietic neoplasms.
Zutter M; Hockenbery D; Silverman GA; Korsmeyer SJ
Blood; 1991 Aug; 78(4):1062-8. PubMed ID: 1868240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]